Close this search box.

Interagency ME / CFS Working Group Meeting 8/11/2020

“Our obligation to the millions suffering worldwide is to provide data-driven information. OMF recognizes this a critical moment in ME/CFS research, with the potential to galvanize efforts to effectively treat and prevent ME/CFS and other related Chronic Complex Diseases.”  

Linda Tannenbaum, OMF CEO & Founder/President,
speaking at the Interagency ME/CFS Working Group Meeting.

Open Medicine Foundations’ ME/CFS and COVID-19 research project was brought into national focus at a recent, federally-sponsored meeting of the first-ever virtual Interagency ME/CFS Working Group Meeting.

This first meeting of the new Working Group focused on ME/CFS and those suffering from post-COVID-19 symptoms (aka “long-haulers”). 

This meeting, unique in its scope, was the first time that representatives of multiple federal research programs met collectively with three leading ME/CFS focused nonprofits, OMF, Solve ME/CFS Initiative and #MEAction. 

Hosted by the NIH and the CDC, representatives of federal research programs included:

  • Three branches of the NIH
  • Three branches of the CDC including the Domestic COVID Response Program 
  • Department of Defense: CDMRP
  • Veterans Administration: Gulf War Research Program 
  • Department of Education: Office of Special Education Programs 
  • Social Security Disability Office 

OMF’s CEO & Founder /President Linda Tannenbaum and OMF’s Chief Medical Officer Ron Tompkins provided an update on the  OMF funded study on COVID-19’s possible conversion to ME/CFS. The presentation can be viewed here.

OMF looks for every opportunity to accelerate research.  The study will examine individuals from early severe COVID-19 illness through their recovery and rehabilitation phase, offering an unprecedented chance to identify biomarkers and discover drug targets and prevention strategies for ME/CFS.

View the slides from the presentation here.

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.

How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669